Hematology Oncology Doctors Abroad — Page 9

Dr. Jiang Fan is a specialist at the clinic and an Associate Chief Physician in the Department of Hematology at Beijing Jingdu Children’s Hospital. She focuses on pediatric hematology with particular experience in hematopoietic stem cell transplantation and childhood immunodeficiency diseases. Her differentiator is transplant-related expertise including umbilical cord blood combined with peripheral stem cell co-transfusion technology, alongside experience in chronic active EB virus infection.

Dr. Liu Zhouyang is a specialist at the clinic and Chief Physician/Director of the Hematology Inpatient Ward at Beijing Jingdu Children’s Hospital. With over 15 years of experience, he manages high-risk pediatric blood disorders including CAEBV and refractory HLH. His differentiator is protocol leadership for infant HSCT: he led the 2024 Chinese Expert Consensus on Infant HSCT Procedures, adopted by over 30 transplant centers, and created a national long-term follow-up database for n=326 infant transplants.

Wang Jian is a radiation oncologist at this clinic. He specializes in radiotherapy for rectal cancer, breast cancer, malignant lymphoma, and cervical cancer. His profile lists radiotherapy for cervical cancer, breast cancer, and colorectal cancer among the treated indications.

Wang Cunbang is a hematologist at this clinic. He specializes in stem cell transplantation for malignant blood diseases and comprehensive treatment of malignant hematologic conditions. His profile also includes diagnosis and treatment of anemia-related diseases, with bone marrow transplantation listed among procedures.

Raúl Martos is a specialist at Uroclínica with a urology oncology and laparoscopic surgery background. He trained and worked as an urology adjunct at Hospital Vall d’Hebrón (2007–2008) and at Parc Taulí in Sabadell (2008–2015), focusing on complex kidney surgery via retroperitoneal laparoscopy. His surgical scope also includes laparoscopic adrenal surgery and laparoscopic cystectomy with multimodal rehabilitation protocols.

Dr. Wu Nanhai is a specialist at the clinic and holds leadership roles as Deputy Director of the Hematology and Oncology Center and Director of Ward 9 at Beijing Jingdu Children’s Hospital. He has nearly 40 years of clinical and academic leadership experience, including early work as Deputy Director of Pediatrics at the Sixth Medical Center of the PLA General Hospital (formerly the Navy General Hospital). His differentiator is combined clinical leadership and academic influence, including Executive Deputy Editor-in-Chief of Chinese Journal of Pediatric Blood and Oncology and membership in major pediatric oncology/hematology professional groups.

Dr. Wu Minyuan is a specialist at the clinic and a Professor/Chief Physician/Doctoral Supervisor in pediatric hematology at Beijing Jingdu Children’s Hospital. She has over 50 years of clinical and academic leadership and is described as a pioneer in childhood leukemia treatment. Her differentiator is protocol leadership: as former Director of the Hematology Center at Beijing Children’s Hospital, she spearheaded national protocols that raised 5-year disease-free survival for pediatric ALL to over 80%, alongside work on risk-stratified chemotherapy and multi-center trials integrating chemotherapy, immunotherapy, and targeted therapies.

Dr. Liu Hongyan is a specialist at the clinic and an Associate Chief Physician in the Department of Hematology and Oncology at Beijing Jingdu Children’s Hospital. She has 15 years of clinical experience focused on childhood blood disorders and cancers. Her differentiator is clinical recognition—she received an Outstanding Physician Award at the former Beijing Armed Police General Hospital’s Pediatric Department—and her training includes a Master’s in Pediatrics from Guangxi Medical University (2010).

Dr. Chen Jiao is a specialist at the clinic and Deputy Chief Physician/Associate Director of the International Medical Department at Beijing Jingdu Children’s Hospital. She focuses on pediatric hematological diseases and immune deficiencies, with clinical work that includes hematopoietic stem cell transplantation and cord blood HSCT. Her differentiator is academic depth—over 50 papers and abstracts including SCI articles, plus MD training at Peking University Health Science Center and doctoral training at Peking University People’s Hospital.

Dr. Tang Suoqin is a specialist at the clinic and Senior Consultant/Distinguished Professor in the Department of Hematology and Oncology at Beijing Jingdu Children’s Hospital. With over 30 years of clinical and academic leadership, he focuses on high-risk neuroblastoma and refractory pediatric solid tumors. His differentiator includes involvement in a Nature Communications 2024 Phase I/II trial (“A Phase I/II Trial”) and ongoing work on AI-driven precision oncology platforms to broaden access to therapies.

Professor Sun Yuan is a specialist at the clinic and a pediatric hematology specialist with nearly 30 years of clinical experience. She pioneered China’s first autologous cord blood transplant for severe aplastic anemia (2009) and improved primary HLH outcomes by shifting HSCT to the first remission phase, reporting 5-year survival of 70%–80%. Her differentiator is full-cycle transplant management: she developed a “1000-Day Post-Transplantation Management Model” with immune monitoring starting 3 months after surgery and early rhGH therapy for growth hormone deficiency.